References
- Obrador GT, Pereira BJ, Kausz AT. Chronic kidney disease in the United States: an underrecognized problem. Semin Nephrol 2002; 22(6): 441–8
- Patel SS, Kimmel PL, Singh A. New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI. Semin Nephrol 2002; 22(6): 449–58
- National Kidney Foundation. Fact sheet: The problem of kidney and urologie disease. January 2005. Available at: http://www.kidney.org. Accessed May 23, 2006
- US Renal Data System. 2003 annual data report: atlas of end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
- National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (2 Suppl 1): S1–266.
- Berns JS, Tokars JI. Preventing bacterial infections and antimicrobial resistance in dialysis patients. Am J Kidney Dis 2002; 40(5): 886–98
- Rodrigo E, de Francisco AL, Escallada R, et al. Measurement of renal function in pre-ESRD patients. Kidney Int Suppl 2002; May (80): 11–7
- Aronoff GR, Berns JS, Brier ME, et al, eds. Drug prescribing in renal failure: dosing guidelines for adults. 4th ed. Philadelphia: American College of Physicians, 1999
- The renal drug book. Available at: http://www.kdp-baptist.louisville.edu/renalbook/. Accessed May 23, 2006
- Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004; 291(19): 2328–34
- Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343(3): 180–4
- Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators. N Engl J Med 2003; 348(6): 491–9
- Kirschbaum BB, Schoolwerth AC. Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids. Am J Med Sci 1989; 297(1): 9–11
- Korzets A, Dicker D, Chaimoff C, et al. Life-threatening hyperphosphatemia and hypocalcemic tetany following the use of Fleet enemas. J Am Geriatr Soc 1992; 40(6): 620–1
- Levey AS, Adler S, Caggiula AW, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis 1996; 27(5): 652–63
- Allon M. Hyperkalemia in end-stage renal disease: mechanisms and management. J Am Soc Nephrol 1995; 6(4): 1134–42